SEC Form 4 · accession 0001415889-15-001975
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leslie L Iversen
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | M | 6,500 | $8.85 | A | 20,000 | D | |
| Common Stock | Jun 1, 2015 | M | 7,627 | $8.85 | A | 27,627 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $8.85 | Jun 1, 2015 | M | 6,500 | D | — | Jun 9, 2015 | Common Stock | 6,500 | 0 | D |
| Stock option (right to buy)F1 | $8.85 | Jun 1, 2015 | M | 7,627 | D | — | Jun 9, 2015 | Common Stock | 7,627 | 0 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following June 10, 2005.